Early beta blocker use after heart attack with fast heart rate or low blood pressure
Treatments studied
Part of Heart & circulation clinical trials.
This trial is testing whether giving a beta-blocker medication (metoprolol) early after a heart attack can help people who have a fast heart rate or low blood pressure but no signs of organ failure. The goal is to see if this treatment improves recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a specific type of heart attack called STEMI, confirmed by an ECG and a catheterization procedure.
- Right after the catheterization, you had a fast heart rate (over 100 beats per minute) or low blood pressure, but without any signs that your organs were not getting enough blood.
- You are 18 years old or older.
- You are able to understand the study and give your consent to participate.
- You are not pregnant, do not have active asthma, severe heart block, a very slow heart rate (below 60), or an allergy to the drug metoprolol.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if ivabradine, a drug that lowers heart rate, can help patients in cardiogenic shock after a type of heart attack called STEMI. It is for patients with a fast heart rate (at least 100 beats per minute) who cannot take beta-blockers.
This trial tests a heart medication (a cardio-selective beta-blocker) given during a heart attack to see if it reduces damage to the heart muscle. It might help people having their first heart attack who are treated quickly with angioplasty (a procedure to open blocked arteries).
This trial tests whether a common beta-blocker (metoprolol) can protect the heart from injury and reduce inflammation after a bleed in the brain (subarachnoid hemorrhage). It may help patients recover better after this type of stroke.
This study tests whether starting a beta blocker and an SGLT2 inhibitor right after a heart attack can help preserve heart function. It is for STEMI patients who have not yet been treated with these medicines.
This trial tests whether giving a clot-busting medication before transferring you to advanced heart attack treatment (PCI—a procedure that opens blocked arteries) is better than waiting. It's for patients having a specific type of heart attack (STEMI) when the advanced treatment center is far away.
This study tests if giving a fast-acting heart medication (esmolol) early through an IV can protect the heart muscle during a heart attack. It may help patients who cannot receive a standard treatment due to certain risks.
Hear when a new ST-segment Elevation Myocardial Infarction (STEMI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.